Insider Shareholders with Direct Ownership of Trevi Therapeutics, Inc. (TRVI)
This section provides a comprehensive overview of the insiders with direct ownership of Trevi Therapeutics, Inc. (TRVI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Trevi Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
New Enterprise Associates 16, L.P.
> 10% Shareholder |
4,483,430 | 0 | 10,421,428 $118 Million | 2 |
Apr 11, 2022
Added 20.16%
|
| 4,555 | 4,555 | 352,489 $3.99 Million | 2 |
Aug 27, 2024
Reduced 1.28%
|
|
|
Thomas Sciascia
Chief Scientific Officer |
109,986 | 104,000 | 221,373 $2.51 Million | 12 |
Mar 25, 2025
Reduced 1.17%
|
|
Jennifer L Good
President & CEO |
96,058 | 96,058 | 213,313 $2.42 Million | 16 |
Mar 21, 2025
Reduced 2.41%
|
|
Farrell Simon
Chief Commercial Officer |
137,563 | 81,313 | 76,900 $871,277 | 4 |
Mar 10, 2025
Reduced 5.35%
|
|
Lisa Delfini
Chief Financial Officer |
67,875 | 18,593 | 64,660 $732,597 | 22 |
Jan 08, 2025
Added 7.18%
|
| 19,225 | 0 | 26,095 $295,656 | 2 |
Dec 02, 2025
Added 13.93%
|
|